BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc.
WKN: 924801 / Symbol: BMRN / Name: BioMarin Pharmaceutical / Aktie / Pharmazeutika / Large Cap /
51,74 €
-0,69 %
BioMarin Pharmaceutical (BMRN) had its price target lowered by Bank of America Corporation from $97.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
BioMarin Pharmaceutical (BMRN) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Ratings data for BMRN provided by MarketBeat
BioMarin Pharmaceutical (BMRN) had its "outperform" rating reaffirmed by Wolfe Research.
Ratings data for BMRN provided by MarketBeat
BioMarin Pharmaceutical (BMRN) is now covered by Morgan Stanley. They set an "overweight" rating and a $120.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
BioMarin Pharmaceutical (BMRN) had its price target lowered by Morgan Stanley from $120.00 to $119.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
BioMarin Pharmaceutical (BMRN) had its price target lowered by Sanford C. Bernstein from $94.00 to $82.00. They now have an "outperform" rating on the stock.
Ratings data for BMRN provided by MarketBeat
BioMarin Pharmaceutical (BMRN) is now covered by Citigroup Inc.. They set a "buy" rating and a $75.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
BioMarin Pharmaceutical (BMRN) had its price target lowered by Bank of America Corporation from $85.00 to $80.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
BioMarin Pharmaceutical (BMRN) had its price target lowered by Canaccord Genuity Group Inc. from $116.00 to $111.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
BioMarin Pharmaceutical (BMRN) had its price target raised by Citigroup Inc. from $75.00 to $76.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Neueste Beiträge
Evercore_Inc_ in Lam Research Corp. diskutieren